Multiomics study and emergency plan optimization of spleen strengthening clearing damp and stomach therapy combined with antiviral therapy for novel coronavirus pneumonia (COVID-19)

Phase 1

• Conditions: ovel Coronavirus Pneumonia (COVID-19)

• Registration Number: ITMCTR2000003063
• Lead Sponsor: i Caixia

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 20 February 2023

Recruitment & Eligibility

• Status: Pending
• Sex: All
• Target Recruitment: Not specified

Inclusion Criteria

Adult patients with confirmed 2019-nCoV

Exclusion Criteria

Severe liver and kidney damage, pulmonary tuberculosis, congenital heart disease, autoimmune disease, interstitial pneumonia, bacterial pneumonia, malignant tumor, history of psychiatric disease

Study & Design

• Study Type: Observational study
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
blood RNA;